3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2
about
Recognition of bacterial signal peptides by mammalian formyl peptide receptors: a new mechanism for sensing pathogens.Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamides as selective agonists of human formyl-peptide receptor 2Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.Radiosynthesis and in vivo Evaluation of Carbon-11 (2S)-3-(1H-Indol-3-yl)-2-{[(4-methoxyphenyl)carbamoyl]amino}-N-{[1-(5-methoxypyridin-2-yl)cyclohexyl]methyl}propanamide: An Attempt to Visualize Brain Formyl Peptide Receptors in Mouse Models of NeuThe Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.Functional N-Formyl Peptide Receptor 2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress.Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation.Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists.
P2860
Q27313685-763E62CF-F843-4971-A622-E4D049A4E87CQ35039823-C60378B7-8F0B-4162-BE65-CA86362C425AQ35417648-8B8F7429-2738-4652-BCDF-A63B192CA5FEQ35738729-34095B2D-D5F5-4D18-AF56-46D60A99FB76Q37011702-950E436B-EBC8-41B2-A09E-8A80F7438B39Q38859451-BF00B869-15F7-4286-966D-29D6313E101FQ39196591-8C58F86C-508A-4A6C-ACD7-B6D6C06C6D90Q41973338-46C76139-70C6-4401-92A3-8EDC84CC6EC3Q46305001-FEC37E38-F768-4CDF-9385-A91E07DA8EA8Q47441885-4D35B279-8428-4990-996C-9DBD01062A7BQ51320454-D888B56C-6101-47F2-9E32-DC9EE17F51F9
P2860
3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
3-(1H-indol-3-yl)-2-[3-(4-nitr ...... of chiral recognition by FPR2
@ast
3-(1H-indol-3-yl)-2-[3-(4-nitr ...... of chiral recognition by FPR2
@en
type
label
3-(1H-indol-3-yl)-2-[3-(4-nitr ...... of chiral recognition by FPR2
@ast
3-(1H-indol-3-yl)-2-[3-(4-nitr ...... of chiral recognition by FPR2
@en
prefLabel
3-(1H-indol-3-yl)-2-[3-(4-nitr ...... of chiral recognition by FPR2
@ast
3-(1H-indol-3-yl)-2-[3-(4-nitr ...... of chiral recognition by FPR2
@en
P2093
P2860
P50
P1476
3-(1H-indol-3-yl)-2-[3-(4-nitr ...... of chiral recognition by FPR2
@en
P2093
Ermelinda Lucente
Igor A Schepetkin
Liliya N Kirpotina
Mark T Quinn
Paola De Giorgio
P2860
P304
P356
10.1016/J.BCP.2012.11.015
P407
P577
2012-12-03T00:00:00Z